$2.55
Market Cap
$1.98M
Shares Outstanding
0.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 21, 2022
Round Lot
100
Locale
US
Day Open
$2.53
Day High
$2.60
Day Low
$2.50
Volume
15.5K
VWAP
$2.53
Prev Close
$2.49
Transactions
--
Acc. Volume
--
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Virax Biolabs Group Limited Ordinary Shares (VRAX) closed the 2026-09-17 session at $2.55, up 2.36% versus the previous close (+0.06). The stock opened at $2.53 and traded between $2.50 and $2.60 during that session. Session trading volume was 15K shares. The volume-weighted average price (VWAP) is $2.53.
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Virax Biolabs Group Limited Ordinary Shares has a market capitalization of $2.0 million. VRAX is listed on the XNAS exchange. The company employs approximately 26 people. The recorded listing date is 2022-07-21.
On this page you can find market VRAX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.